| Trial ID: | L0101 |
| Source ID: | NCT01289639
|
| Associated Drug: |
Fenofibrate
|
| Title: |
Insulin Resistance in Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01289639/results
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Drug: fenofibrate|Drug: pioglitazone|Drug: placebo
|
| Outcome Measures: |
Liver/Spleen Ratio Measured as the Ratio in Hounsfield Units Between the Liver and the Spleen on Computed Tomography (CT) Scan|Change in Alanine Aminotransferase (ALT) Levels|Change in Liver/Spleen Ratio Measure by the Density Ratio in Hounsfield Units Between the Liver and the Spleen by CT|Change in Peripheral Insulin Sensitivity|Change in Intra-abdominal Fat Area by CT Scan|Change in Hepatic Insulin Sensitivity
|
| Sponsor/Collaborators: |
VA Office of Research and Development
|
| Gender: |
All
|
| Age: |
18 Years to 80 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
11
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science
|
| Start Date: |
October 2005
|
| Completion Date: |
August 2014
|
| Results First Posted: |
October 20, 2014
|
| Last Update Posted: |
August 17, 2017
|
| Locations: |
VA Puget Sound Health Care System, Seattle, Seattle, Washington, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01289639
|
